Jan-Erik Palmgren
Papers
3
Total Citations
51
H-Index
2
About
Jan-Erik Palmgren is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT) for genitourinary and gynecologic cancers. His major contributions center on advancing hypofractionated, high-precision radiation techniques to improve treatment outcomes for localized prostate cancer. Palmgren authored the first Nordic clinical experience with SBRT for prostate cancer (2017, 26 citations), demonstrating the feasibility and safety of this emerging modality. He further solidified this impact with a landmark 5-year efficacy study (2020, 23 citations), providing crucial long-term, real-world data that supports SBRT as a primary treatment—a key reference for clinicians adopting this approach. His work also explores robotic SBRT versus MR-guided brachytherapy for cervical cancer, showcasing his breadth in image-guided radiation. With over 50 cumulative citations on these core papers, Palmgren’s research directly shapes modern practice, offering patients shorter, more precise treatment courses. His contributions are especially notable for bridging early clinical adoption with robust long-term evidence, making him a pivotal figure in the evolution of stereotactic radiation therapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3